INTRODUCTION: The role of 5-lipoxygenase (5-LO) in colon cancer is unknown. Tumor-infiltrating macrophages, neutrophils, and mast cells have been shown to play important roles in colon tumorigenesis and are dependent on 5-LO for function. METHODS AND MATERIALS: Utilizing the APC(Δ468) polyposis model, we performed 5-LO gene knockouts and evaluated the subsequent changes in macrophage, neutrophil, and mast cell density at the tumor site. The proliferative and degranulation capacities of 5-LO-deficient mast cells were also measured, quantifying thymidine incorporation and β-hexosaminidase release, respectively. RESULTS: APC(Δ468)/5LO(-/-) mice displayed increased tumor-infiltrating macrophages and decreased neutrophils at the polyp site. In vitro, mast cells deficient for 5-LO proliferated at a diminished rate while mast cell degranulation was unchanged. DISCUSSION: We provide evidence suggesting that 5-LO deficiency has differential effects on the infiltration of macrophages and neutrophils in adenomatous polyps, increasing and decreasing infiltration of these cells, respectively. Our observations are consistent with a protective role for tumor-infiltrating macrophages in the initiation of polyp formation. The mechanisms through which 5-LO deficiency negatively affects these cells are under investigation. CONCLUSIONS: These results provide evidence that 5-LO plays an important role in tumorigenesis and further indicate that 5-LO-selective inhibitors can be investigated as potential therapeutic agents for colorectal polyposis and cancer.
INTRODUCTION: The role of 5-lipoxygenase (5-LO) in colon cancer is unknown. Tumor-infiltrating macrophages, neutrophils, and mast cells have been shown to play important roles in colon tumorigenesis and are dependent on 5-LO for function. METHODS AND MATERIALS: Utilizing the APC(Δ468) polyposis model, we performed 5-LO gene knockouts and evaluated the subsequent changes in macrophage, neutrophil, and mast cell density at the tumor site. The proliferative and degranulation capacities of 5-LO-deficient mast cells were also measured, quantifying thymidine incorporation and β-hexosaminidase release, respectively. RESULTS:APC(Δ468)/5LO(-/-) mice displayed increased tumor-infiltrating macrophages and decreased neutrophils at the polyp site. In vitro, mast cells deficient for 5-LO proliferated at a diminished rate while mast cell degranulation was unchanged. DISCUSSION: We provide evidence suggesting that 5-LO deficiency has differential effects on the infiltration of macrophages and neutrophils in adenomatous polyps, increasing and decreasing infiltration of these cells, respectively. Our observations are consistent with a protective role for tumor-infiltrating macrophages in the initiation of polyp formation. The mechanisms through which 5-LO deficiency negatively affects these cells are under investigation. CONCLUSIONS: These results provide evidence that 5-LO plays an important role in tumorigenesis and further indicate that 5-LO-selective inhibitors can be investigated as potential therapeutic agents for colorectal polyposis and cancer.
Authors: Eric C Cheon; Khashayarsha Khazaie; Mohammad W Khan; Matthew J Strouch; Seth B Krantz; Joseph Phillips; Nichole R Blatner; Laura M Hix; Ming Zhang; Kristen L Dennis; Mohammed R Salabat; Michael Heiferman; Paul J Grippo; Hidayatullah G Munshi; Elias Gounaris; David J Bentrem Journal: Cancer Res Date: 2011-01-07 Impact factor: 12.701
Authors: Johan Forssell; Ake Oberg; Maria L Henriksson; Roger Stenling; Andreas Jung; Richard Palmqvist Journal: Clin Cancer Res Date: 2007-03-01 Impact factor: 12.531
Authors: Chris Corrigan; Kirsty Mallett; Sun Ying; David Roberts; Abhi Parikh; Glenis Scadding; Tak Lee Journal: J Allergy Clin Immunol Date: 2005-02 Impact factor: 10.793
Authors: John F Ohd; Christian Kamp Nielsen; Joan Campbell; Göran Landberg; Helge Löfberg; Anita Sjölander Journal: Gastroenterology Date: 2003-01 Impact factor: 22.682
Authors: Laleh G Melstrom; David J Bentrem; Mohammad R Salabat; Timothy J Kennedy; Xian-Zhong Ding; Matthew Strouch; Sambasiva M Rao; Richard C Witt; Charles A Ternent; Mark S Talamonti; Richard H Bell; Thomas A Adrian Journal: Clin Cancer Res Date: 2008-10-15 Impact factor: 12.531
Authors: Joanna M Poczobutt; Teresa T Nguyen; Dwight Hanson; Howard Li; Trisha R Sippel; Mary C M Weiser-Evans; Miguel Gijon; Robert C Murphy; Raphael A Nemenoff Journal: J Immunol Date: 2015-12-11 Impact factor: 5.422